XML 35 R26.htm IDEA: XBRL DOCUMENT v3.24.3
LICENSE AND COLLABORATION AGREEMENTS (Tables)
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Certain Activity Related to Revenue with Supply Agreement The following table summarizes certain Roche activity for the three and nine months ended September 30, 2024:

 

 

For the Three Months Ended
September 30, 2024

 

 

For the Nine Months Ended
September 30, 2024

 

 

(in thousands)

 

Contract manufacturing revenue

$

27,891

 

 

$

33,698

 

Royalty revenue

$

9,510

 

 

$

12,066

 

Cost of sales (inventory costs related to products sold to Roche)

$

13,725

 

 

$

15,379